baber/WOPTO huggingface dataset:
Patent AU-2020325675-A1 (AU)
Title: Pyrenoid-like structures
Inventor: MCCORMICK ALISTAIR JAMES
IPC: C12N9/88
Filed: 2020-07-31
Abstract: Aspects of the present disclosure relate to genetically altered plants having a modified Rubisco and further having a modified Essential Pyrenoid Component 1 (EPYC1) for formation of an aggregate of modified Rubisco and EPYC1 polypeptides. Other aspects of the present disclosure relate to methods of making such plants as well as cultivating these genetically altered plants.
Patent AU-2020338051-A1 (AU)
Title: Bio-printed kidney tissue
Inventor: LITTLE MELISSA H
IPC: B33Y80/00
Filed: 2020-08-21
Abstract: The present disclosure relates to bio-printed kidney tissue and methods of manufacturing the same. The bio-printed tissue and methods may be used in a variety of applications such as regenerative medicine.
Patent AU-2020341071-A1 (AU)
Title: Heat-sterilized and packed beverage containing high concentration of medium chain triglyceride
Inventor: NONAKA SHOTA
IPC: A23F5/40
Filed: 2020-09-02
Abstract: Provided is a heat-sterilized containerized beverage containing a high concentration of a medium-chain fatty acid triglyceride (MCT) and obtained by heat sterilization, wherein issues of poor aftertaste and throat discomfort caused by a combination of a high concentration of the MCT and heat sterilization are resolved. The heat-sterilized containerized beverage is obtained by causing 10-120 mg/100 ml of caffeine to coexist with a beverage containing 1.2-32 g/100 ml of the MCT.
Patent AU-2020348231-A1 (AU)
Title: Nanoparticle pharmaceutical delivery system
Inventor: KILLGORE KENDALL
IPC: A61K47/16
Filed: 2020-09-14
Abstract: A method of preparing a nanoparticle pharmaceutical delivery system. A nanoparticle pharmaceutical delivery system. A method of preparing a targeted nanoparticle pharmaceutical delivery system. A targeted nanoparticle pharmaceutical delivery system.
Patent AU-2020348916-A1 (AU)
Title: Detection of antibodies against RAN proteins from serum and tissue lysates
Inventor: RANUM LAURA
IPC: C12Q1/68
Filed: 2020-09-18
Abstract: Aspects of the disclosure relate to methods and compositions (e.g., kits) for detecting anti-repeat-associated non-ATG (RAN) protein antibodies in a subject (e.g., a subject that has been administered a therapeutic anti-RAN protein antibody or a vaccine against a disease or disorder associated with RAN protein expression, translation, and/or accumulation, for example amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD)). In some embodiments, methods described by the disclosure comprise detecting one or more anti-RAN protein antibodies in a biological sample obtained from a subject by an electrochemiluminescence-based immunoassay using one or more target di-amino acid repeat peptides. In some embodiments, the disclosure relates to kits comprising one or more di-amino acid repeat peptides and an electrochemiluminescence-based immunoassay plate and/or reagents.
Patent AU-2020351229-A1 (AU)
Title: Systems and methods for precision matched immunoglobulin infusion
Inventor: SEALFON ANDREW
IPC: A61M1/00
Filed: 2020-09-18
Abstract: Systems, administration sets, and methods of manufacturing for delivering an infusion fluid into a patient's anatomic space include a controller pre-set to deliver a desired flow rate of infusion fluid and an administration set matched to the controller, the administration set includes a pre-determined number of flow tubes having diameters and lengths selected based upon the desired flow rate and number of infusion sites for a specific infusion fluid treatment.
Patent AU-2020352931-A1 (AU)
Title: Modulating genomic complexes
Inventor: LANDE LAURA GABRIELA
IPC: C12N15/113
Filed: 2020-09-22
Abstract: The present disclosure relates generally to modulation of genomic complexes via modulation of non- genomic components such as, non-coding RNAs.
Patent AU-2020354669-A1 (AU)
Title: Characterization of gene therapy viral particles using size exclusion chromatography and multi-angle light scattering technologies
Inventor: BHAT VIKAS
IPC: G01N15/02
Filed: 2020-09-25
Abstract: This disclosure relates to the use of size exclusion chromatography and/or size exclusion chromatography with multi-angle light scattering technology to characterize viral particles such as adeno-associated virus and lentivirus particles. The disclosed methods are also useful for estimating the titer of viral particles, determining the integrity of the viral particles and estimating the amount of DNA encapsidated in the viral particle.
Patent AU-2020356334-A1 (AU)
Title: Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
Inventor: VANDERMEULEN GAËLLE
IPC: A61P35/00
Filed: 2020-09-24
Abstract: The present invention relates to a vaccine for treating and/or preventing a brain tumor. More particularly, the invention relates to a modified vesicular stomatitis virus glycoprotein (VSV-G) comprising at least one tumor antigen, or a fragment thereof, for use in preventing and/or treating a brain tumor in an individual in need thereof, when administered before a surgery intended to remove all or part of the tumor, such as, a tumor resection. The inventors have shown that vaccination of individual with a brain tumor with a vaccine comprising a nucleic acid sequence encoding a modified VSV-G according to the invention may be combined to a tumor resection in order to ameliorate the prognostic of said individuals.
Patent AU-2020359123-A1 (AU)
Title: Securing member and wall structure
Inventor: SAWADA YOHEI
IPC: E04F13/08
Filed: 2020-09-29
Abstract: Provided are a wall structure that has high strength and can stably support a wall material, and a securing member that is used in the wall structure. The wall structure includes a securing member 10 that fixes a wall material 2 to a building frame 8. The securing member 10 includes a substrate portion 15, a bulging portion 30 that bulges from the substrate portion 15 and extends in a left-right direction, a contact surface 31 that comes into contact with the rear surface of the wall material 2, and a locking portion 13 that engages the wall material 2. The bulging portion 30 has bulging portions 30E and 30F, the substrate portion 15 includes an end-side fixing portion 17 on an end side in the left-right direction, the end-side fixing portion 17 is surrounded in the left-right direction and on the lower side by the bulging portions 30, 30E, and 30F, and the inner-side bulging portion 30F adjacent on the inner side to the end-side fixing portion 17 of the bulging portions 30E and 30F is inclined such that the width in the left-right direction increases toward the locking portion 13. In the securing member 10, the end-side fixing portion 17 on one end side is fixed to the building frame 8, and the end-side fixing portion 17 on the other end side supports the wall material 2 using the locking portion 13 in a state of not being fixed.
Patent AU-2020381091-A1 (AU)
Title: Additive manufacturing of silica aerogel objects
Inventor: ZHAO SHANYU
IPC: C01B33/158
Filed: 2020-11-06
Abstract: An ink composition for additive manufacture of silica aerogel objects essentially consists of a gellable silica sol containing an admixture of 30 to 70 vol.-% of a mesoporous silica powder in a base solvent. The mesoporous silica powder has a particle size range of 0.001 to 1 mm and a tap density of 30 to 200 kg/m3 and comprises at least 10% by weight of silica aerogel powder. The composition has a yield stress in the range of 30 to 3000 Pa and a viscosity of 5 to 150 Pa·s at a shear rate of 50s-1. Furthermore, the composition has shear thinning properties defined as a reduction in viscosity by a factor between 10 and 103 for an increase in shear rate by a factor of 104 to 105. A method of additive manufacturing of a three-dimensional silica aerogel object by direct ink writing comprises providing such ink composition, forcing the same through a convergent nozzle, thereby forming a jet of the ink composition which is directed in such manner as to form a three-dimensional object by additive manufacturing. After initiating and carrying out gelation of the gellable silica sol constituting said object, a drying step yields the desired three-dimensional silica aerogel object.
Patent AU-2021201597-A1 (AU)
Title: Systems and Methods for Supplementing Captured Data
Inventor: WOMACK MARCUS W L
IPC: H04N21/231
Filed: 2021-03-12
Abstract: A method for redacting and presenting captured data in real time or near real time, the captured 
data includes at least video data organized as frames, the method performed by a processor, the 
captured data, one or more records of identified data, and alignment data stored in a memory 
system, the method comprising: for a frame of the captured data: identifying, using the alignment 
data, each location in the frame where identified data may need to be removed, wherein the 
identified data comprises a portion of data in the frame; generating a description of the identified 
data, wherein the description comprises a description of semantic data, a description of audio 
data, and a description of visual data from the identified data; storing the description of the 
identified data in the one or more records of identified data; comparing the description of the 
identified data from the one or more records of identified data to one or more rules, wherein the 
one or more rules are stored in the memory system, wherein the one or more rules comprise a 
semantic rule, a visual rule, and an audio rule, wherein the comparing the description comprises 
applying at least one of the one or more rules to the description of semantic data, the description 
of audio data, or the description of visual data, and wherein the one or more rules are applied 
based on an intended use of the captured data; determining whether the identified data should be 
removed in the frame based on the comparing; and responsive to determining that the identified 
data should be removed from the frame, preparing a presentation copy of the frame, the 
presentation copy includes the captured data in which the identified data has been removed, 
otherwise, preparing the presentation copy of the frame so that the presentation copy includes the 
captured data without alteration; and presenting the presentation copy of the frame.
Patent AU-2021201884-A1 (AU)
Title: Networked Intoxication Vehicle Immobilization
Inventor: DEVRIES DOUGLAS EDWARD
IPC: B60W10/18
Filed: 2021-03-25
Abstract: A vehicle immobilization system includes a detection element operable to detect a level 
of an intoxicant in a user's breath. A control module is operable to receive a signal from the 
detection element indicating the level of intoxicant in the user's breath, and to selectively restrict 
operation of a vehicle based on the level of intoxicant in the user's breath exceeding a threshold.  
A wireless relay is operable to replace a standard relay in the vehicle, and to wirelessly 
communicate with the control module such that the control module is operable to control the 
wireless relay to selectively restrict operation of the vehicle.
-- 800 
-1aCE1 -{AQ1 
-a2 b2k -. 2 b2f -j.2 b2f~ PROCESSOR COMMUNICATION 
PROCESSO 3 MODULE 
802 MEMORY 804 
814 
INPUT 806 OUTPUT 808 
OPERATING SYSTEM 816 
STORAGE 
DEVICE NETWORK SERVICE 818 
INTOXICATION -- 820 
INTERLOCK APPLICATION 
812 
FIG. 8
Patent AU-2021202600-A1 (AU)
Title: Compositions and methods for the treatment of type 1 diabetes
Inventor: ROTTIERS PIETER
IPC: C12N1/00
Filed: 2021-04-27
Abstract: COMPOSITIONS AND METHODS FOR THE TREATMENT OF TYPE 1 DIABETES 
ABSTRACT 
Provided herein are compositions and methods for the treatment of type 1 diabetes (TID) in 
mammalian subjects. The compositions include lactic acid fermenting bacteria (LAB) expressing 
an IL-2 gene and a TID-specific self-antigen (e.g., proinsulin (PINS)) gene. Exemplary methods 
include: orally administering to a mammalian subject, a therapeutically effective amount of the 
composition. The composition can be administered to the subject mucosally, resulting in delivery 
of the LAB into the gastrointestinal tract, where the LAB is released. Bioactive polypeptides 
expressed by the LAB are thus administered via mucosal delivery. The LAB may be selected to 
deliver a low-dose of IL-2 to the subject. The methods may not require concomitant systemic 
anti-CD3 antibody treatment. The methods may be suited for subjects possessing residual beta
cell function, e.g., those with recent-onset TID.
Patent AU-2021203685-A1 (AU)
Title: Identifying status of male fertility by determining sperm capacitation
Inventor: ALEXANDER J TRAVIS
IPC: G01N33/68
Filed: 2021-06-04
Abstract: This disclosure provides a method for determining male fertility status. The method comprises 
determining GM1 distribution patterns following induced sperm capacitation, identifying the 
frequency of distribution of various patterns, and determining if the frequency distribution of 
certain GM1 patterns in response to induced capacitation is altered. Based on the change in the 
frequency distribution patterns of certain patterns in response to induced capacitation, alone or in 
combination with other sperm attributes, male fertility status can be identified.
Patent AU-2021205034-A1 (AU)
Title: Process for monitoring vehicles by a plurality of sensors
Inventor: ALLIOT SAMUEL
IPC: G01S13/86
Filed: 2021-07-14
Abstract: The invention relates to a process for monitoring vehicles on a road by a system 
comprising at least one radar sensor and a second sensor different from the radar sensor, 
wherein the second remote sensor is a time-of-flight optical sensor or optical image 
sensor, the process comprising a temporal readjustment and a spatial matching (S3) in 
order to obtain a set of measurement points each assigned to first characteristics derived 
from the radar data and second characteristics derived from the optical data, the 
determination of the radar vehicle trackings (S4) and of the optical vehicle trackings (S5), 
a comparison of similarity (S6) between the radar vehicle trackings and the optical vehicle 
trackings, the elimination (S7) of the radar vehicle trackings for which no optical vehicle 
tracking is similar, the process comprising monitoring (S8) a parameter derived from first 
characteristics of a retained radar vehicle tracking.  
Figure for the abstract: Fig. 2 
1
2/2 
FIG 2 
S1 Radar data stream Second data stream S2 
S3 temporal readjustment and 
spatial matching 
S4 First vehicle trackings Second vehicle trackings S 5 
Comparison of similarity between the S6 
trackings 
Elimination of the first vehicle trackings S7 
Monitoring of a derived parameter S8
Patent AU-2021210902-A1 (AU)
Title: Apparatus and method to join a coupler and flow tube in an ultrasonic flow meter
Inventor: VERMA KAUSHAL
IPC: G01F1/66
Filed: 2021-01-21
Abstract: A flow sensor sub-assembly for sensing flow of a fluidic medicament includes a flow tube having an inlet and an outlet, a first coupler secured to the inlet of the flow tube, a second coupler secured to the outlet of the flow tube, a first piezo element secured to the first coupler, a second piezo element secured to the second coupler to define a predetermined distance between the first piezo element and the second piezo element, and at least one absorber sleeve engaged with the first coupler, the flow tube, and the second coupler.
Patent AU-2021221681-A1 (AU)
Title: Service pillar
Inventor: DUGGAN SIMON PETER JAMES
IPC: G16Y40/50
Filed: 2021-08-25
Abstract: A service pillar (100) for connecting a consumer (10) to a service provider network (12), the 
service pillar (100) comprising: a housing (102); at least one terminal (132-138) disposed in the 
housing (110), the at least one terminal (123-138) configured to connect the consumer (10) to the 
service provider network (12); and a damage detection unit (150), the damage detection unit 
(150) including: at least one sensor (160-170) disposed in the housing (110) and configured to 
detect potential damage to the housing (110); and a communication device (154) wherein the 
damage detection unit (150) is configured to communicate, by the communication device (154), 
a signal and wherein the signal includes or is based on at least one output from the at least one 
sensor (160-170).
1/6 
AV-
Patent AU-2021227504-A1 (AU)
Title: Stitched reinforcing fiber base material, preform material, fiber reinforced composite material, and manufacturing methods for same
Inventor: AKAMATSU TETSUYA
IPC: D04H3/04
Filed: 2021-02-22
Abstract: An objective of the present invention is to provide a stitched reinforcing fiber base material that can inhibit the formation of micro-cracks in fiber reinforced composite materials.　A stitched reinforcing fiber base material according to the present invention is formed by using stitching thread to stitch reinforcing fiber sheets formed from reinforcing fibers, the stitching thread having a polar group-containing organic compound adhered thereto. The polar group-containing organic compound is preferably a compound having a polyoxyalkylene skeleton and is preferably a compound having an epoxy group. The amount of the polar group-containing organic compound adhered to the stitching thread is preferably 0.1-10wt% with respect to the mass of the stitching thread.
Patent AU-2021232708-A1 (AU)
Title: Packaging apparatus
Inventor: ICHIKAWA MAKOTO
IPC: B65B43/26
Filed: 2021-09-15
Abstract: Providing a packaging apparatus that can reduce the possibility that packages 
inconsistent with desired specifications is manufactured due to an optional device being 
mistakenly set to an operative or inoperative setting. A bag-making and packaging apparatus 
5 operates a bag-making and packaging unit to manufacture bags containing articles inside, and 
a gas replacement device can be optionally attached to the bag-making and packaging 
apparatus. The bag-making and packaging apparatus includes an operation control unit that 
controls the operation of the bag-making and packaging unit, a first detection unit that detects 
whether or not the gas replacement device is attached to the bag-making and packaging 
10 apparatus, a second detection unit that detects whether a setting of the gas replacement device 
is set to an operative setting or an inoperative setting, a notification unit that issues a 
notification of information relating to the gas replacement device, and a notification control 
unit. The notification control unit makes the notification unit issue a notification that the 
setting of the gas replacement device is set to the inoperative setting in a case where the first 
15 detection unit detects that the gas replacement device is attached to the bag-making and 
packaging apparatus and the second detection unit detects that the setting of the gas 
replacement device is set to the inoperative setting before the operation of the bag-making and 
packaging unit is started.  
Selected Drawing FIG. 6 
20
6/7 
GAS REPLACEMENT 
DEVICE: OPERATIVE 
F I G. 7 
GAS REPLACEMENT 
DEVICE: INOPERATIVE 
GAS REPLACEMENT DEVICE IS 
SET TO INOPERATIVE SETTING.  
OK CHANGE 
F I G. 8 
GAS REPLACEMENT 
DEVICE: INOPERATIVE 
F I G. 9
Patent AU-2021235569-A1 (AU)
Title: Shedding blocking agents with increased stability
Inventor: HAKIM MOTTI
IPC: C07K16/28
Filed: 2021-03-11
Abstract: Agents comprising at least two moieties separated by a linker, wherein a first moiety binds mCD28 on a surface of a cell and inhibits proteolytic cleavage of the mCD28 and wherein a second moiety increases stability of the first moiety are provided. Methods of treating cancer and improving immunotherapy comprising administering the agents are also provided.
Patent AU-2021240258-A1 (AU)
Title: Electronic gaming machine, game controller and method
Inventor: RAE CLAUDIA
IPC: G07F17/32
Filed: 2021-09-30
Abstract: A game controller configured to, in response to input of a wager, execute n game 
rounds, wherein n = b+f game rounds, where b base game rounds are executed 
followed by f feature game rounds, using symbol data defining a set of a plurality of 
symbols for each of m reels wherein for up to m-1 reels, the plurality of symbols 
includes one or more special symbols, wherein for each base game round the game 
controller selects a plurality of symbols from the sets defining the m reels for display in a 
set of symbols positions as a game outcome and for each occurrence of the special 
symbol, for the reel on which the special symbol appears, increment a counter up to a 
count limit for the reel based on the wager, wherein the count persists for the base 
game rounds; and for each feature game round: perform a wild reel substitution for each 
reel where the reel count satisfies eligibility criterion, and select a plurality of symbols for 
the non-wild substituted reels; and determine an award of credits based on winning 
combinations of symbols in the selected symbols.  
29
S - , 
<- I 
I Z W C 
<w i 
I 2 
5L L
Patent AU-2021254542-A1 (AU)
Title: Prefabricated roof panel
Inventor: GUY TODD WILLIAM
IPC: E04D3/35
Filed: 2021-10-19
Abstract: A prefabricated structural roof panel having a length (I) extending between two ends 
and a width (w) extending between two lateral sides (s1 and s2), the panel 
comprising: an outer external sheet configured to provide a roof for a building a 
structure; an inner internal sheet configured to provide a ceiling for a building 
structure; an insulating core assembly positioned between the outer external sheet 
and the inner sheet; the core comprising: a first core comprising a first solid material, 
the first core portion extending across the width of the panel and having a length (11) 
extending along a first section of the length (I) of the panel, and a second core 
comprising a second solid material, the second core portion extending across the 
width of the panel and having a length (12) and extending along a second section of 
the length (I) of the panel.
110 104 
100 
W --
FIGURE 1 
100 
134 
130 
132 
FIGURE 2
Patent AU-2021257979-A1 (AU)
Title: An improved toilet hygiene apparatus
Inventor: BURGIS WAYNE
IPC: E03D9/02
Filed: 2021-10-27
Abstract: The present invention provides a packaging box, including a box body; the box body is provided 
with an insertable zone; a dashed hole is disposed at an edge of the insertable zone. The 
insertable zone is round and may be completely or partially separated from the box body; there 
is an insertable zone on the box body. The packaging box provided by the present invention 
has an insertable zone. The detecting personnel need not find out an extra tubular fixed seat for 
use. Meanwhile, a packaging box is used to replace a tubular fixed seat, reducing the use cost 
of the detecting apparatus. Moreover, each lysis tube can be inserted into respective packaging 
box; and each packaging box is corresponding to respective detecting apparatus. Therefore, it 
is not easy to cause the misuse of lysis tubes during loading and detection procedure, thereby 
avoiding wrong detection because the lysis tube is taken by mistake.
1/4 
A 
20 
Fig.1 
21 
20 
10 
Fig.2
Patent AU-2021265578-A1 (AU)
Title: Azalactam compounds as HPK1 inhibitors
Inventor: BARBER JOYANN
IPC: C07D519/00
Filed: 2021-04-28
Abstract: This invention relates to compounds of general Formula (I) and pharmaceutically acceptable salts thereof, in which R